This inverse correlation between TRIM6 and anti-PD-1 response was further confirmed in highly immunogenic melanoma [32] (Supplementary Fig. 1j), supporting TRIM6’s conserved role in immunotherapy regulation. The gene discussed is TRIM6; the disease is melanoma.